Galmed Pharma (GLMD) Tops Q1 EPS by 7c

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Jefferies Upgrades Yihai International Holding Ltd. (1579:HK) (YNNHF) to Buy
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance